Compare Cai Lay Veterinary Pharmaceutical JSC with Similar Stocks
Stock DNA
Pharmaceuticals & Biotechnology
VND 95,000 Million (Micro Cap)
8.00
NA
0.00%
-0.21
10.48%
0.98
Revenue and Profits:
Net Sales:
39,470 Million
(Quarterly Results - Dec 2025)
Net Profit:
6,984 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
77.18%
0%
77.18%
6 Months
172.16%
0%
172.16%
1 Year
186.96%
0%
186.96%
2 Years
161.39%
0%
161.39%
3 Years
101.53%
0%
101.53%
4 Years
88.57%
0%
88.57%
5 Years
-10.2%
0%
-10.2%
Cai Lay Veterinary Pharmaceutical JSC for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
5.13%
EBIT Growth (5y)
12.12%
EBIT to Interest (avg)
70.52
Debt to EBITDA (avg)
0.36
Net Debt to Equity (avg)
-0.26
Sales to Capital Employed (avg)
1.34
Tax Ratio
20.35%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
15.78%
ROE (avg)
9.28%
Valuation key factors
Factor
Value
P/E Ratio
8
Industry P/E
Price to Book Value
0.54
EV to EBIT
2.64
EV to EBITDA
1.92
EV to Capital Employed
0.41
EV to Sales
0.23
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
15.51%
ROE (Latest)
6.93%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
No Trend
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
Dec'25
Sep'25
Change(%)
Net Sales
39,470.40
42,159.80
-6.38%
Operating Profit (PBDIT) excl Other Income
10,458.10
9,401.70
11.24%
Interest
1,049.40
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
6,984.40
5,689.50
22.76%
Operating Profit Margin (Excl OI)
238.00%
193.40%
4.46%
USD in Million.
Net Sales
QoQ Growth in quarter ended Dec 2025 is -6.38% vs 24.64% in Sep 2025
Consolidated Net Profit
QoQ Growth in quarter ended Dec 2025 is 22.76% vs 150.73% in Sep 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
148,868.90
107,036.50
39.08%
Operating Profit (PBDIT) excl Other Income
28,526.40
16,290.40
75.11%
Interest
4,106.50
38.50
10,566.23%
Exceptional Items
0.00
0.00
Consolidate Net Profit
16,900.90
7,324.30
130.75%
Operating Profit Margin (Excl OI)
163.60%
112.70%
5.09%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 39.08% vs -3.49% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 130.75% vs 18.11% in Dec 2024
About Cai Lay Veterinary Pharmaceutical JSC 
Cai Lay Veterinary Pharmaceutical JSC
Pharmaceuticals & Biotechnology
Cai Lay Veterinary Pharmaceutical Joint Stock Company is a Vietnam-based pharmaceutical company. It is engaged in the manufacture and trading of medicine and veterinary pharmaceutical products. The Company also manufactures and trades nutrition and feedstuff for animals. It is involved in the retail of drugs, medical equipment, cosmetics and sanitary products in specialized shops. In addition, the Company is involved in aquaculture and fishing activities, agricultural and forestry product processing, seafood trading, wood processing and the manufacture of wood furniture and other products for outdoor and indoor decoration purposes. It also trades breeding plants and fertilizers. The Company announces that AUSTFEED Vietnam Joint Stock Co has acquired 1,059,983 shares in the Company on February 22, 2013, raising its stake in the Company from 17.77% to 57.19%.
Company Coordinates 
Company Details
Khu pho 1, phuong 5, thi xa Cai Lay , TIEN GIANG None : None
Registrar Details






